| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $700.4M | +7.2% |
| Cost of Revenue | $173.4M | +7.1% |
| Gross Profit | $527.0M | +7.3% |
| R&D Expense | $109.2M | +8.1% |
| SG&A Expense | $118.7M | -2.5% |
| Operating Income | $25.6M | +37.9% |
| Pre-tax Income | $48.2M | -61.3% |
| Income Tax | $21.0M | +148.7% |
| Net Income | $24.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $390.0M | -56.0% |
| Accounts Receivable | $218.1M | +22.4% |
| Current Assets | $1.03B | -6.2% |
| Total Assets | $1.76B | -3.6% |
| Current Liabilities | $695.4M | +64.7% |
| Total Liabilities | $1.39B | +3.4% |
| Stockholders' Equity | $332.3M | -25.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $169.6M | -11.1% |
| Capital Expenditures | $8.1M | +279.8% |
| Investing Cash Flow | -$425.3M | -146.0% |
| Financing Cash Flow | -$240.1M | +52.0% |
| Free Cash Flow | $161.5M | -14.4% |
| -84.8% |
| EPS (Basic) | $0.40 | -84.6% |
| EPS (Diluted) | $0.39 | -73.1% |